Arcus biosciences to participate in the goldman sachs 43rd annual global healthcare conference

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in a fireside chat at the upcoming goldman sachs 43rd annual global healthcare conference at the terranea resort in rancho palos verdes, california. the fireside chat will take place on thursday, june 16th, 2022 at 9:20 a.m. pt. a liv
RCUS Ratings Summary
RCUS Quant Ranking